Galiñanes M, Hearse D J
Department of Cardiovascular Research, Rayne Institute, St. Thomas' Hospital, London, United Kingdom.
J Thorac Cardiovasc Surg. 1992 Jul;104(1):151-8.
Impaired coronary flow during postischemic reperfusion may limit functional recovery. In the present studies we used the heterotopically transplanted rat heart and the isolated working rat heart to assess whether adenosine, given during reperfusion, could improve either the rate or the extent of postischemic recovery. Hearts were arrested (2 minutes at 4 degrees C) with the St. Thomas' Hospital cardioplegic solution and stored by immersion in the same solution for 8 hours at 4 degrees C. Hearts were then transplanted into the abdomen of homozygous recipients. Immediately before reperfusion, adenosine (0.5 ml of a 1 mumol/L solution, equivalent to 0.13 micrograms) was injected into the left ventricle (control rats received an equivalent amount of saline). Hearts were reperfused in vivo for 30 minutes or 24 hours, after which they were excised and perfused (Langendorff) for 20 minutes for the assessment of function. They were then freeze clamped and taken for metabolic analysis. After 50 minutes of reperfusion, left ventricular developed pressure was 75 +/- 5 mm Hg (4 mm Hg end-diastolic pressure) in the adenosine group versus 61 +/- 4 mm Hg in the control group (p less than 0.05); however, after 24 hours function was identical in the two groups (52 +/- 4 versus 52 +/- 3 mm Hg). After 50 minutes of reperfusion coronary flow was greater in the adenosine group (11.0 +/- 0.4 versus 9.7 +/- 0.4 ml/min in control rats; p less than 0.05), a difference that was sustained for 24 hours (12.8 +/- 0.3 versus 11.4 +/- 0.4 ml/min in control rats; p less than 0.05). Adenosine triphosphate and creatine phosphate contents recovered to similar extents in control and adenosine groups after both 50 minutes and 24 hours of reperfusion. In further studies with an identical storage protocol (8 hours at 4 degrees C), hearts were not transplanted but were reperfused with crystalloid medium in the Langendorff mode for 15 minutes (creatine kinase leakage measured) and in the working mode for 180 minutes. In an attempt to mimic the heterotopic transplant protocol, adenosine (1 mumol/L) was included in the perfusion fluid for the first 2 minutes of reperfusion. Similar results to those of the transplant studies were obtained, with coronary flow being consistently improved in the adenosine group; however, this benefit was lost after only 2 hours of reperfusion.(ABSTRACT TRUNCATED AT 400 WORDS)
缺血后再灌注期间冠状动脉血流受损可能会限制功能恢复。在本研究中,我们使用异位移植的大鼠心脏和离体工作的大鼠心脏来评估再灌注期间给予腺苷是否能改善缺血后恢复的速度或程度。心脏用圣托马斯医院心脏停搏液停搏(4℃下2分钟),并浸泡在相同溶液中于4℃保存8小时。然后将心脏移植到同基因受体的腹部。在再灌注前,将腺苷(0.5ml 1μmol/L溶液,相当于0.13μg)注入左心室(对照大鼠接受等量的生理盐水)。心脏在体内再灌注30分钟或24小时,之后将其取出并进行Langendorff灌注20分钟以评估功能。然后将其冷冻钳夹并进行代谢分析。再灌注50分钟后,腺苷组左心室舒张末压为75±5mmHg(舒张压4mmHg),而对照组为61±4mmHg(p<0.05);然而,24小时后两组功能相同(52±4对52±3mmHg)。再灌注50分钟后,腺苷组冠状动脉血流更大(11.0±0.4对对照组的9.7±0.4ml/min;p<0.05),这种差异持续24小时(12.8±0.3对对照组的11.4±0.4ml/min;p<0.05)。再灌注50分钟和24小时后,对照组和腺苷组三磷酸腺苷和磷酸肌酸含量恢复程度相似。在采用相同保存方案(4℃下8小时)的进一步研究中,心脏未进行移植,而是在Langendorff模式下用晶体培养基再灌注15分钟(测量肌酸激酶泄漏),并在工作模式下再灌注180分钟。为了模拟异位移植方案,在再灌注的前2分钟将腺苷(1μmol/L)加入灌注液中。获得了与移植研究相似的结果,腺苷组冠状动脉血流持续改善;然而,仅再灌注2小时后这种益处就消失了。(摘要截短至400字)